GENMAB A/S shareholders Q3 2023

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 229 filers reported holding GENMAB A/S in Q3 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.0%.

GENMAB A/S shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 52,148$1,839,2601.67%
Ativo Capital Management LLC 28,442$1,003,1321.13%
HARDING LOEVNER LP 3,204,230$113,013,1830.75%
Hardman Johnston Global Advisors LLC 592,318$20,891,0560.70%
Yorktown Management & Research Co Inc 16,600$585,4820.66%
TORRAY INVESTMENT PARTNERS LLC 104,516$3,686,2790.65%
First Light Asset Management, LLC 157,147$5,542,5750.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 44,300$1,561,5750.53%
Capricorn Fund Managers Ltd 37,007$1,305,2370.45%
Legacy Wealth Asset Management, LLC 29,496$1,040,3240.38%
NAVELLIER & ASSOCIATES INC 25,600$902,9120.16%
MACQUARIE GROUP LTD 3,249,736$114,618,0000.14%
Moloney Securities Asset Management, LLC 22,704$800,7700.14%
ALLIANCEBERNSTEIN L.P. 9,515,209$335,601,4210.14%
Marotta Asset Management 16,451$580,2270.13%
FOLKETRYGDFONDET 170,385$6,009,4790.12%
TRANSATLANTIQUE PRIVATE WEALTH LLC 6,271$2210.12%
1832 Asset Management L.P. 2,243,600$79,131,7720.11%
Geller Advisors LLC 27,300$962,8710.11%
LVW Advisors, LLC 15,030$530,1090.11%
External links

This page lists GENMAB A/S's shareholders in Q3 2023. To view GENMAB A/S's shareholder history, click here.